Robert E. Landry, EVP Finance CFO at REGENERON PHARMACEUTICALS, INC. (REGN), sold 669 shares at $677.00 ($455K) on 2022-03-16, disclosed to the SEC on 2022-03-18.
Open-market sale of $455k REGN by EVP Finance CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $677.00 | 300 | $203K | 44.6% |
| 2 | $682.50 | 286 | $195K | 42.9% |
| 3 | $686.00 | 83 | $57K | 12.5% |
| Total | $680.47 avg | 669 | $455K | 100% |
| Filing → |
| REGN | SELL | 2023-08-25 | $188K | — | Filing → |
| REGN | SELL | 2023-03-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-02-07 | $2.1M | — | Filing → |